Susquehanna International Group’s Phibro Animal Health PAHC Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$370K Buy
6,698
+987
+17% +$47K ﹤0.01% 10400
2025
Q4
$213K Sell
5,711
-41,241
-88% -$1.68M ﹤0.01% 10739
2025
Q3
$1.9M Buy
46,952
+9,727
+26% +$321K ﹤0.01% 5903
2025
Q2
$951K Buy
37,225
+3,722
+11% +$81.2K ﹤0.01% 7560
2025
Q1
$716K Buy
33,503
+17,513
+110% +$391K ﹤0.01% 8088
2024
Q4
$336K Buy
15,990
+4,157
+35% +$96.2K ﹤0.01% 9580
2024
Q3
$266K Buy
+11,833
New +$228K ﹤0.01% 9845
2024
Q2
Sell
-15,211
Closed -$197K 12918
2024
Q1
$197K Buy
15,211
+1,491
+11% +$17.9K ﹤0.01% 10607
2023
Q4
$159K Buy
+13,720
New +$155K ﹤0.01% 10917
2023
Q2
Sell
-22,533
Closed -$345K 12843
2023
Q1
$345K Buy
+22,533
New +$344K ﹤0.01% 9419
2021
Q3
Sell
-10,836
Closed -$313K 13327
2021
Q2
$313K Buy
+10,836
New +$293K ﹤0.01% 10693
2019
Q4
Sell
-12,147
Closed -$259K 10384
2019
Q3
$259K Buy
12,147
+1,322
+12% +$36.2K ﹤0.01% 8621
2019
Q2
$344K Buy
+10,825
New +$339K ﹤0.01% 8054
2018
Q3
Sell
-5,863
Closed -$277K 9963
2018
Q2
$270K Buy
+5,863
New +$260K ﹤0.01% 8050
2017
Q3
Sell
-5,923
Closed -$219K 9405
2017
Q2
$219K Buy
+5,923
New +$193K ﹤0.01% 8130
2017
Q1
Sell
-26,922
Closed -$789K 9678
2016
Q4
$789K Buy
+26,922
New +$735K ﹤0.01% 6018
2016
Q2
Sell
-16,500
Closed -$446K 9124
2016
Q1
$446K Buy
16,500
+6,255
+61% +$179K ﹤0.01% 6607
2015
Q4
$309K Sell
10,245
-24,735
-71% -$794K ﹤0.01% 7638
2015
Q3
$1.11M Buy
34,980
+24,326
+228% +$888K ﹤0.01% 5526
2015
Q2
$415K Sell
10,654
-15,523
-59% -$535K ﹤0.01% 7979
2015
Q1
$927K Buy
+26,177
New +$843K ﹤0.01% 5910
2014
Q3
Sell
-45,790
Closed -$1M 9797
2014
Q2
$1M Buy
+45,790
New +$870K ﹤0.01% 6042

Other funds holding PAHC

Susquehanna International Group's PAHC Position: Q1 2026 in Review

Susquehanna International Group increased its Phibro Animal Health (PAHC) stake by 17% in Q1 2026, buying an estimated $47K and bringing the position to 6,698 shares worth $370K. The position accounts for ﹤0.01% of the portfolio, ranked #10400.

Susquehanna International Group first reported a position in PAHC in Q2 2014 and has held it in 22 quarters since. The position peaked at $1.9M in Q3 2025. 257 funds tracked by Wall St. Rank hold PAHC as of Q1 2026.

  • Susquehanna International Group held 6,698 shares of Phibro Animal Health worth $370K as of Q1 2026.
  • Susquehanna International Group bought 987 Phibro Animal Health shares in Q1 2026, an estimated $47K.
  • Phibro Animal Health made up ﹤0.01% of Susquehanna International Group's portfolio in Q1 2026, its #10400 holding.
  • Susquehanna International Group first reported a position in Phibro Animal Health in Q2 2014 and has held it in 22 quarters since.
  • Susquehanna International Group's Phibro Animal Health position peaked at $1.9M in Q3 2025.
  • 257 funds tracked by Wall St. Rank held Phibro Animal Health as of Q1 2026.

Based on Susquehanna International Group's 13F filing for Q1 2026, filed 15 May 2026.